GILEAD SCIENCES, INC. Ttl Offering Amt
GILEAD SCIENCES, INC. (GILD) had Ttl Offering Amt of $0 as of 2026-07-29, per its S-3ASR filed 2026-08-06.
Financial Statements › Notes
ffd:TtlOfferingAmt · last filed 2026-08-06
- 2026-07-29: Ttl Offering Amt $0.00.
- 2026-05-15: Ttl Offering Amt $3.00B.
- 2026-05-07: Ttl Offering Amt $6.21B.
| Period end | Ttl Offering Amt |
|---|---|
| 2026-07-29 | $0.00 S-3ASR · filed 2026-08-06 |
| 2026-05-15 | $3.00B 424B5 · filed 2026-05-18 |
| 2026-05-07 | $6.21B S-8 · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |